Journal articleHuman

Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009 Dec. Sackmann-Sala L, Ding J, Frohman LA and 1 others.

Study type
Journal article
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Published
2009 Dec
PubMed
PMID 19386527 ↗
DOI
10.1016/j.ghir.2009.03.001 ↗
Full text
Free on PubMed Central (PMC2787983) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Mod-GRF (1-29) →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AdultBiomarkersBlood ProteinsElectrophoresis, Gel, Two-DimensionalGrowth HormoneGrowth Hormone-Releasing HormoneHumansHypothalamusInsulin-Like Growth Factor IMaleMass SpectrometryModels, Biological

Other papers on Mod-GRF (1-29)

Randomized controlled trial · 2006
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Clinical trial · 2006
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
Journal article · 2010
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds